Exchange seeks clarification on modified audit opinion disclosure

VIVIMEDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹6.21

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.3%+0.4% vs market

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-1.9-2.3+0.4

Next day

-3.9-1.9-1.9

-5.6-0.2-5.4

-7.4-0.2-7.2

-9.2+0.5-9.7

-11.0pendingpending

———

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

For the quarter ended 31 March 2026, the exchange asked Vivimed Labs why it did not submit the required Statement of Impact of Audit Qualifications for modified audit opinions. The company has not yet responded, and no penalty or other regulatory action has been announced.

Likely market impact

The pending query may raise compliance and governance concerns, but no penalty or market restriction has been announced.